V. Khoo

发表

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

Ali Amin Al Olama, T. Sellers, D. Schaid, 2009, Nature Genetics.

Multiple newly identified loci associated with prostate cancer susceptibility

Ali Amin Al Olama, D. English, J. Morrison, 2008, Nature Genetics.

Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

D. Dearnaley, A. Horwich, V. Khoo, 1999, The Lancet.

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder

R. Eeles, D. Dearnaley, A. Horwich, 2015, British Journal of Cancer.

Early clinical evaluation of a novel three-dimensional structure delineation software tool (SCULPTER) for radiotherapy treatment planning.

P Price, V S Khoo, C J Moore, 2008, The British journal of radiology.

New developments in MRI for target volume delineation in radiotherapy.

V S Khoo, V. Khoo, D. L. Joon, 2006, The British journal of radiology.

A Comparison of clinical target volumes determined by CT and MRI for the radiotherapy planning of base of skull meningiomas.

V S Khoo, J L Bedford, A P Warrington, 2000, International journal of radiation oncology, biology, physics.

Pan-cancer analysis of whole genomes

Steven J. M. Jones, Nuno A. Fonseca, Icgc, 2020, Nature.

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets

C. Sander, L. Matthews, S. Tavaré, 2018, Nature Genetics.

Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity?

V. Khoo, R. Cowan, J. Logue, 2004, International journal of radiation oncology, biology, physics.

Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies.

D. Dearnaley, V. Khoo, D. Tait, 2012, European journal of cancer.

X-ray volumetric imaging in image-guided radiotherapy: the new standard in on-treatment imaging.

V. Khoo, T. Marchant, J. Sykes, 2006, International journal of radiation oncology, biology, physics.

Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning.

D. Dearnaley, V. Khoo, A. Padhani, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide.

Stine Korreman, Uwe Oelfke, Dirk Verellen, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy.

John Staffurth, Emma Hall, Helen McNair, 2015, International journal of radiation oncology, biology, physics.

An evaluation of three-field coplanar plans for conformal radiotherapy of prostate cancer.

S. Webb, D. Dearnaley, V. Khoo, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Assessment of bladder motion for clinical radiotherapy practice using cine-magnetic resonance imaging.

Christopher J Moore, David L Buckley, Charles E Hutchinson, 2009, International journal of radiation oncology, biology, physics.

Radiotherapy for renal-cell carcinoma.

V. Khoo, M. Mareel, A. Briganti, 2014, The Lancet. Oncology.

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy.

G G Hanna, G J Webster, V. Khoo, 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

A randomized study of the use of a customized immobilization system in the treatment of prostate cancer with conformal radiotherapy.

D P Dearnaley, V S Khoo, D. Dearnaley, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy

D. Dearnaley, V. Khoo, K. Harrington, 2005, British Journal of Cancer.

Imaging for Radiotherapy Treatment Planning

V. Khoo, 2009 .

Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-up

R. Eeles, D. Dearnaley, A. Horwich, 2013, British Journal of Cancer.

Feasibility of Comparative Health Research Outcome of Novel Surgery in prostate cancer (IP4-CHRONOS): statistical analysis plan for the randomised feasibility phase of the CHRONOS study

M. Sydes, V. Khoo, H. Ahmed, 2021, Trials.

Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment

D. Dearnaley, A. Horwich, R. Huddart, 2017, International journal of radiation oncology, biology, physics.

Assessing intra-fractional bladder motion using cine-MRI as initial methodology for Predictive Organ Localization (POLO) in radiotherapy for bladder cancer.

D. Dearnaley, A. Horwich, R. Huddart, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prostate Motion: Implications and Management Strategies

V. Khoo, N. V. As, A. Tree, 2012 .

Implementation and Comparison of Different Segmentation Techniques for Medical Images

Priyanka, G. Burdea, D. Dearnaley, 2016 .

Dose-volume response in acute dysphagia toxicity: Validating QUANTEC recommendations into clinical practice for head and neck radiotherapy

V. Khoo, M. Schneider-Kolsky, D. L. Joon, 2014, Acta oncologica.

An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation.

V. Khoo, A. Thompson, J. Kyula, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Supportive care needs of men living with prostate cancer in England: a survey

V. Khoo, A. Richardson, J. Wilson‐Barnett, 2008, British Journal of Cancer.

Achieving the relocation accuracy of stereotactic frame-based cranial radiotherapy in a three-point thermoplastic shell.

V. Khoo, K. Pennert, S. Ashley, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Assessing Bladder Radiotherapy Response With Quantitative Diffusion-Weighted Magnetic Resonance Imaging Analysis.

R. Huddart, V. Khoo, A. Sohaib, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

Letter in response to Dearnaley et al. letter regarding paper: Evaluating the efficacy of statins and angiotensin converting enzyme-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies.

V. Khoo, D. Tait, L. Wedlake, 2013, European journal of cancer.

Fiducial markers: can the urologist do better?

V. Khoo, N. Lawrentschuk, D. L. Joon, 2018, World Journal of Urology.

Controversies in the radiotherapeutic management of poor prognosis locally advanced prostate cancer.

D. Dearnaley, V. Khoo, R. Cowan, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Grand Round Controversies in the Radiotherapeutic Management of Poor Prognosis Locally Advanced Prostate Cancer

D. Dearnaley, V. Khoo, R. Cowan, 2004 .

Self‐management after prostate cancer treatment: evaluating the feasibility of providing a cognitive and behavioural programme for lower urinary tract symptoms

V. Khoo, S. Faithfull, J. Cockle-Hearne, 2011, BJU international.

Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial

V. Khoo, H. Ahmed, J. McGrath, 2021, BMJ Open.

New concepts in prostate cancer management: the conundrum of managing oligometastatic disease in prostate cancer-through the looking glass darkly.

V. Khoo, 2019, Clinical radiology.

Prostate Cancer Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA 2 Mutation Carriers

W. Foulkes, A. Ardern-Jones, E. Page, 2019 .

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

L. Kiemeney, L. Andrews, R. Eeles, 2019, European urology.

Acquired immunodeficiency syndrome-related primary cerebral lymphoma.

V. Khoo, K. Liew, 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

Stereotactic body radiotherapy for oligometastases.

Merina Ahmed, R. Eeles, D. Dearnaley, 2013, The Lancet. Oncology.

Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer—Prevalence and Current Clinical Practice

R. Eeles, V. Khoo, C. Parker, 2022, Frontiers in Oncology.

A Randomised Trial of Conventional Care versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases

V. Khoo, N. V. As, K. Franks, 2018, Clinical Oncology.

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder

R. Eeles, D. Dearnaley, A. Horwich, 2015, British Journal of Cancer.

High dose rate brachytherapy boost for prostate cancer: Biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomes

V. Khoo, J. Wasiak, N. Lawrentschuk, 2019, Journal of medical imaging and radiation oncology.

Adjuvant chemoradiotherapy for gastric carcinoma: dosimetric implications of conventional gastric bed irradiation and toxicity.

V. Khoo, L. Perry, M. Saunders, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

Investigating the relationship between virtual cystoscopy image quality and CT slice thickness.

R. Huddart, V. Khoo, S. Sohaib, 2012, The British journal of radiology.

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

J. R. Wilson, David M. Holden, P. W. Foster, 2016, British Journal of Cancer.

Conformal radiotherapy, intensity-modulated radiotherapy and image-guided radiotherapy

V. Khoo, 2008 .

The Testing of Prostate IGRT in Clinical Trials

D. Dearnaley, V. Khoo, 2008 .

Fiducial markers in external beam radiotherapy for bladder cancer.

V. Khoo, A. Thompson, S. Lalondrelle, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

C. Porta, J. Patard, V. Khoo, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Predicting late effects of pelvic radiotherapy: is there a better approach?

V. Khoo, D. Tait, L. Wedlake, 2010, International journal of radiation oncology, biology, physics.

Relationship of Ki‐67 labeling index to DNA‐ploidy, S‐phase fraction, and outcome in prostate cancer treated with radiotherapy

V. Khoo, P. Troncoso, A. V. von Eschenbach, 1999, The Prostate.

Working patterns and perceived contribution of prostate cancer clinical nurse specialists: a mixed method investigation.

V. Khoo, A. Richardson, J. Wilson‐Barnett, 2009, International journal of nursing studies.

Detection of occult spinal cord compression with magnetic resonance imaging of the spine.

D. Dearnaley, A. Horwich, R. Huddart, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Is supplementation with elemental diet feasible in patients undergoing pelvic radiotherapy?

V. Khoo, K. Harrington, A. Norman, 2006, Clinical nutrition.

A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading.

V. Khoo, K. Harrington, A. Norman, 2006, International journal of radiation oncology, biology, physics.

Technological advances in radiotherapy for the treatment of localised prostate cancer.

Alan Horwich, D. Dearnaley, A. Horwich, 2005, European journal of cancer.

RADBIOMOD: A simple program for utilising biological modelling in radiotherapy plan evaluation.

V. Khoo, S. Gill, R. Prabhakar, 2016, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Class solutions for conformal external beam prostate radiotherapy.

S. Webb, D. Dearnaley, V. Khoo, 2003, International journal of radiation oncology, biology, physics.

Optimization of coplanar six-field techniques for conformal radiotherapy of the prostate.

D. Dearnaley, V. Khoo, J. Bedford, 2000, International journal of radiation oncology, biology, physics.

Evaluation of the optimal co-planar field arrangement for use in the boost phase of dose escalated conformal radiotherapy for localized prostate cancer.

D. Dearnaley, V. Khoo, J. Bedford, 2001, The British journal of radiology.

Hypoxia-targeted radiotherapy dose painting for head and neck cancer using 18F-FMISO PET: A biological modeling study

V. Khoo, A. Scott, G. O'Keefe, 2013, Acta oncologica.

An assessment of clinically optimal gold marker length and diameter for pelvic radiotherapy verification using an amorphous silicon flat panel electronic portal imaging device.

V. Khoo, C. Moore, A. Henry, 2005, The British journal of radiology.

The collaborative management of late urological complications after radiation therapy

V. Khoo, J. Wasiak, F. Foroudi, 2019, BJU international.

Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation study.

A. Horwich, R. Huddart, V. Khoo, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation.

V. Khoo, M. Hasegawa, A. Pollack, 1997, International journal of radiation oncology, biology, physics.

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

Suzanne Chambers, Peter Kraft, Henrik Gronberg, 2011, Nature Genetics.

Phase I dose-escalated image-guided adaptive bladder radiotherapy study: Results of first dose cohort (68Gy).

D. Dearnaley, A. Horwich, R. Huddart, 2014 .

Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer

R. Eeles, D. Dearnaley, R. Huddart, 2017, International journal of radiation oncology, biology, physics.

Escalated-dose Conformai Radiotherapy for Localised Prostate Cancer: Long-term Overall Survival Results From the MRC RT01 Randomised Controlled Trial

M. Sydes, D. Dearnaley, V. Khoo, 2011 .

Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy.

V. Khoo, P. Troncoso, A. V. von Eschenbach, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: a phase II study.

V. Khoo, H. Pandha, S. Nair, 2007, The Journal of urology.

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder

R. Eeles, D. Dearnaley, A. Horwich, 2015, British Journal of Cancer.

Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial

D. Dearnaley, V. Khoo, J. Staffurth, 2022, International journal of radiation oncology, biology, physics.

The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial.

D. Dearnaley, V. Khoo, C. Parker, 2018, International journal of radiation oncology, biology, physics.

Pretreatment risk stratification of feeding tube use in patients treated with intensity‐modulated radiotherapy for head and neck cancer

V. Khoo, D. L. Joon, M. Poulsen, 2018, Head & neck.

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

C. Porta, N. Rioux-Leclercq, A. Horwich, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Is There Another Bite of the Cherry? The Case for Radical Local Therapy for Oligometastatic Disease in Prostate Cancer.

V. Khoo, 2016, European urology.

Unresolved issues in the management of locally advanced non-metastatic pancreas cancer.

V. Khoo, P. Price, 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

Results of a randomised phase II study of hypofractionated bladder radiotherapy (RT) with or without image guided adaptive planning (HYBRID - CRUK/12/055).

R. Huddart, V. Khoo, J. Staffurth, 2017 .

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees.

W. Oyen, T. H. van der Kwast, M. Babjuk, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

The effect of antiemetics and reduced radiation fields on acute gastrointestinal morbidity of adjuvant radiotherapy in stage I seminoma of the testis: a randomized pilot study.

D. Dearnaley, A. Horwich, V. Khoo, 1997, Clinical oncology (Royal College of Radiologists (Great Britain)).

Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital

R. Eeles, D. Dearnaley, V. Khoo, 2017, Clinical genitourinary cancer.

Clinical Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced Penile Squamous‐Cell Carcinoma: Results of a Multicenter Analysis

G. Pond, V. Khoo, G. Sonpavde, 2017, Clinical genitourinary cancer.

Modern management of penile cancer

V. Khoo, 2013, EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.].

Predictors of histological disease progression in untreated, localized prostate cancer.

D. Dearnaley, A. Horwich, R. Huddart, 2007, The Journal of urology.

University of Southern Denmark Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

L. Kiemeney, L. Andrews, R. Eeles, 2018 .

The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates

Edward R. W. Rowe, David C. Jones, L. Matthews, 2022, Molecular Cancer.

Anal canal cancer and chemoradiation treatment in two patients with systemic lupus erythematosus treated by chronic therapeutic immunosuppression.

V. Khoo, B. Cummings, P. Price, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.

Matthew Sydes, Colin Cooper, Alan Horwich, 2008, The Lancet. Oncology.

Taste preferences for oral nutrition supplements in patients before and after pelvic radiotherapy: a double-blind controlled study.

V. Khoo, K. Whelan, K. Harrington, 2006, Clinical nutrition.

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

Warren C. Grant, M. Parmar, M. Sydes, 2021, The Lancet.

Metastatic prostate cancer men’s attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment study

V. Khoo, H. Ahmed, M. Genie, 2021, BMJ Open.

Outcome of early detection and radiotherapy for occult spinal cord compression.

R. Eeles, D. Dearnaley, A. Horwich, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparison of hypofractionated high-dose intensity-modulated radiotherapy schedules for prostate cancer: Results from the phase III randomized CHHiP trial (CRUK/06/016).

D. Dearnaley, V. Khoo, J. Logue, 2016 .

Intensity modulated radiation therapy allows prostate and dose-escalated pelvic radical radiation therapy after renal transplantation.

V. Khoo, N. Van As, R. Corbett, 2015, Practical radiation oncology.

Clinical trial: Efficacy of a low or modified fat diet for the prevention of gastrointestinal toxicity in patients receiving radiotherapy treatment for pelvic malignancies.

D. Dearnaley, V. Khoo, D. Tait, 2012, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

Locally advanced rectal cancer: surgical complications after infusional chemotherapy and radiation therapy.

V. Khoo, J. Skibber, T. Rich, 1998, Radiology.

The dosimetric advantages of perirectal hydrogel spacer in men with localized prostate cancer undergoing stereotactic ablative radiotherapy (SABR).

V. Khoo, Y. Suh, Philippa Sturt, 2022, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Simple Segment IMRT: Dosimetric and Resource Implications of an Innovative Rectal Cancer Technique

V. Khoo, D. L. Joon, D. Scandurra, 2013 .

Diffusion-weighted MRI to determine response and long-term clinical outcomes in muscle-invasive bladder cancer following neoadjuvant chemotherapy

R. Huddart, V. Khoo, J. d’Arcy, 2022, Frontiers in Oncology.

What Is Oligometastatic Prostate Cancer?

P. Boutros, V. Khoo, P. Tran, 2019, European urology focus.

Radical Treatment Without Cure: Decision-making in Oligometastatic Prostate Cancer.

V. Khoo, H. Ahmed, V. Watson, 2021, European urology.

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

Neil L. Aaronson, L. Kiemeney, L. Andrews, 2018, British Journal of Cancer.

Impact of Prostate Cancer Hypofractionation on Patient Reported Outcomes: Baseline to 5 Years Change in the CHHIP Trial

D. Dearnaley, V. Khoo, C. Parker, 2018, International Journal of Radiation Oncology*Biology*Physics.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Annie Gao, Clare Griffin, John Staffurth, 2016, The Lancet. Oncology.

Biological dose escalation and hypofractionation: what is there to be gained and how will it best be done?

D. Dearnaley, V. Khoo, N. Van As, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer.

D P Dearnaley, V S Khoo, J D Fenwick, 2001, International journal of radiation oncology, biology, physics.

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

C. Porta, N. Rioux-Leclercq, J. Patard, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical Outcomes of Stereotactic Body Radiotherapy With Immediate Versus Delayed Hormone Therapy in Men With Oligometastatic Recurrence of Prostate Cancer.

V. Khoo, N. deSouza, N. Van As, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Expression of Bcl-2, p53, and MDM2 in localized prostate cancer with respect to the outcome of radical radiotherapy dose escalation.

M. Sydes, R. Eeles, D. Dearnaley, 2010, International journal of radiation oncology, biology, physics.

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

C. Porta, N. Rioux-Leclercq, A. Horwich, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Patterns of somatic structural variation in human cancer genomes

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2020, Nature.

Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial.

V. Khoo, Robert J. Jones, S. Crabb, 2022, European urology.

Multiple loci on 8q24 associated with prostate cancer susceptibility

Ali Amin Al Olama, D. English, J. Morrison, 2009, Nature Genetics.

Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials.

V. Khoo, H. Ahmed, M. Winkler, 2020, European urology oncology.

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2020, Nature Communications.

Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial

D. Dearnaley, V. Khoo, C. Parker, 2019, Clinical and translational radiation oncology.

Treatment outcomes for small cell carcinoma of the bladder: results from a UK patient retrospective cohort study.

R. Huddart, V. Khoo, N. Vasudev, 2021, International journal of radiation oncology, biology, physics.

Clinical Translation of Positive Metastases Identified on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging in the Management of De Novo Synchronous Oligometastatic Prostate Cancer.

V. Khoo, H. Ahmed, H. Tam, 2020, European urology focus.

The utility of multimodality imaging with CT and MRI in defining rectal tumour volumes for radiotherapy treatment planning: a pilot study

V. Khoo, D. L. Joon, G. Fitt, 2010, Journal of medical imaging and radiation oncology.

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

Peter Kraft, Anssi Auvinen, Henrik Gronberg, 2013, Nature Genetics.

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.

Suzanne Chambers, Peter Kraft, Anssi Auvinen, 2013, Human molecular genetics.

Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood.

V. Khoo, E. Adams, B. Baumert, 2002, International journal of radiation oncology, biology, physics.

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

L. Kiemeney, R. Eeles, Z. Kote-Jarai, 2014, European urology.

Prostate‐specific membrane antigen‐positron emission tomography/computed tomography (PSMA‐PET/CT)‐guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single‐institution experience and review of the published literature

V. Khoo, N. Lawrentschuk, D. Bolton, 2019, BJU international.

A novel, spontaneously immortalized, human prostate cancer cell line, Bob, offers a unique model for pre‐clinical prostate cancer studies

V. Khoo, A. Thompson, C. Cooper, 2009, The Prostate.

Acute vascular embolus resulting from metastatic endocardial involvement with synovial sarcoma: report of a case and review of the literature.

V. Khoo, S. Ngan, M. Guiney, 1997, Australasian radiology.

Proximal seminal vesicle displacement and margins for prostate cancer radiotherapy

V. Khoo, N. Lawrentschuk, F. Foroudi, 2021, Journal of medical radiation sciences.

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Annie Gao, Clare Griffin, John Staffurth, 2015, The Lancet. Oncology.

Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.

V. Khoo, A. Scott, I. Davis, 2015, International journal of radiation oncology, biology, physics.

MRI scans significantly change target coverage decisions in radical radiotherapy for prostate cancer

Morikatsu Wada, Vincent Khoo, George Quong, 2014, Journal of medical imaging and radiation oncology.

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.

M. Parmar, M. Sydes, D. Dearnaley, 2014, The Lancet. Oncology.

Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma

V. Khoo, A. Scott, H. Tochon-Danguy, 2014, European Radiology.

Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre

V. Khoo, D. L. Joon, G. Quong, 2011, Cancers.

Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy.

Damien Bolton, Sylvia J Gong, Vincent Khoo, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans.

Damien Bolton, Sylvia J Gong, Vincent Khoo, 2012, International journal of radiation oncology, biology, physics.

The use of hydrogel spacer in men undergoing high-dose prostate cancer radiotherapy: results of a prospective phase 2 clinical trial

V. Khoo, N. Lawrentschuk, D. Bolton, 2018, World Journal of Urology.

The changing landscape of head and neck cancer radiotherapy patients: is high‐risk, prolonged feeding tube use indicative of on‐treatment weight loss?

V. Khoo, M. Poulsen, H. Gan, 2019, Journal of medical radiation sciences.

18F-FDG Metabolic Tumor Volume: Association with Short- and Long-Term Feeding Tube Use in Head and Neck IMRT

V. Khoo, D. L. Joon, M. Poulsen, 2018, Dysphagia.

Patterns of recurrence after prostate bed radiotherapy.

R. Eeles, D. Dearnaley, R. Huddart, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prostate cancer post-prostatectomy radiotherapy: CT vs MRI for vesico-urethral anastomosis target delineation.

V. Khoo, N. Lawrentschuk, F. Foroudi, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Defining primary anal cancer tumour volume on FDG–PET – an initial assessment of semi–automated methods

V. Khoo, D. L. Joon, F. Foroudi, 2021, International Journal of Radiology & Radiation Therapy.

Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)

V. Khoo, S. Sundar, S Kumar, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

V. Khoo, N. Lawrentschuk, N. Hardcastle, 2018, BMC Cancer.

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

R. Eeles, Z. Kote-Jarai, F. Hamdy, 2021, The Lancet. Oncology.

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees.

M. Babjuk, T. D. de Reijke, S. Culine, 2019, European urology.

Clinical trial: normal diet vs. partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapy

V. Khoo, K. Harrington, A. Norman, 2008, Alimentary pharmacology & therapeutics.

ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer

V. Khoo, Robert J. Jones, S. Crabb, 2017, Investigational New Drugs.

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

C. Porta, N. Rioux-Leclercq, A. Horwich, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance

R. Eeles, A. Horwich, R. Huddart, 2009, Prostate Cancer and Prostatic Diseases.

Spine and Non-spine Bone Metastases - Current Controversies and Future Direction.

V. Khoo, R. Ashford, R. Olson, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer.

Bradley R Pieters, Vincent Khoo, Berardino De Bari, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Identification of new genetic risk factors for prostate cancer.

D. English, J. Morrison, R. Eeles, 2009, Asian journal of andrology.

Long‐term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis

V. Khoo, L. Pickering, L. Vyas, 2020, BJU international.

Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors.

M. Oldham, V. Khoo, J. Bedford, 1999, International journal of radiation oncology, biology, physics.

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact

D. English, R. Eeles, Z. Kote-Jarai, 2011, Genetic epidemiology.

Assessing the impact of FDG-PET in the management of anal cancer.

V. Khoo, A. Scott, D. L. Joon, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intensity Modulated Radiation Therapy Dose Painting for Localized Prostate Cancer Using 11 C-choline Positron

V. Khoo, A. Scott, I. Davis, 2012 .

IMRT dose painting for localized prostate cancer using 11C-choline PET scans.

V. Khoo, A. Scott, I. Davis, 2012 .

2433: Determination of Accuracy in the Delineation of Spinal Cord and Canal/Thecal Sac on CT and MRI in Head and Neck Planning

V. Khoo, D. L. Joon, M. Feigen, 2006 .

Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance.

Alan Horwich, D. Dearnaley, A. Horwich, 2008, European urology.

W. Oyen, M. Babjuk, S. Culine, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.

V. Khoo, W. Ryder, R. Cowan, 2002, International journal of radiation oncology, biology, physics.

A Systematic Review of Patients’ Values, Preferences, and Expectations for the Treatment of Metastatic Prostate Cancer

V. Khoo, H. Ahmed, M. Genie, 2021, European urology open science.

Comprehensive molecular characterization of mitochondrial genomes in human cancers

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2017, bioRxiv.

Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay

V. Khoo, A. Zietman, K. Haustermans, 2019, BJU international.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.

Annie Gao, John Staffurth, Peter Kirkbride, 2012, The Lancet. Oncology.

Question of dose, fractionation and technique: ingredients for testing hypofractionation in prostate cancer--the CHHiP trial.

D P Dearnaley, V S Khoo, D. Dearnaley, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).

Steve Webb, Stefano Gianolini, S. Webb, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Can biological markers act as non‐invasive, sensitive indicators of radiation‐induced effects in the gastrointestinal mucosa?

D. Dearnaley, V. Khoo, K. Harrington, 2008, Alimentary pharmacology & therapeutics.

Sex differences in oncogenic mutational processes

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2019, Nature Communications.

Improved methods for adding transaxial two-dimensional margins to the superior and inferior regions of a clinical target volume.

D. Dearnaley, V. Khoo, J. Bedford, 1999, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

SCULPTER: fast evidence based 3D anatomy sculpting in radiotherapy by computerised topological self-mapping

Christopher J. Moore, Jonathan R. Sykes, Philip J. Sharrock, 2003, CARS.

Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial.

D. Dearnaley, V. Khoo, B. Seddon, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Imaging Advances for Target Volume Definition in Radiotherapy

V. Khoo, V. Suárez-Gironzini, 2015, Current Radiology Reports.

The value of new imaging technology for target volume delineation.

V. Khoo, 2009, European journal of cancer.

A pilot study investigating the role of 18F‐FDG‐PET in the early identification of chemoradiotherapy response in anal cancer

V. Khoo, D. L. Joon, F. Foroudi, 2022, Journal of medical radiation sciences.

Clinical and dosimetric risk stratification for patients at high-risk of feeding tube use during definitive IMRT for head and neck cancer

V. Khoo, D. L. Joon, M. Poulsen, 2020, Technical innovations & patient support in radiation oncology.

A comparison of treatment planning techniques used in two randomised UK external beam radiotherapy trials for localised prostate cancer.

D. Dearnaley, V. Khoo, A. Norman, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Neoadjuvant androgen deprivation therapy for prostate volume reduction, lower urinary tract symptom relief and quality of life improvement in men with intermediate- to high-risk prostate cancer: a randomised non-inferiority trial of degarelix versus goserelin plus bicalutamide.

V. Khoo, T. Wiegel, M. Mason, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Is biochemical relapse-free survival after profoundly hypofractionated radiotherapy consistent with current radiobiological models?

V. Khoo, M. Partridge, N. Van As, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy.

V. Khoo, V. Khoo, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis.

V. Khoo, R. Cowan, J. Logue, 2002, International journal of radiation oncology, biology, physics.

Adjuvant therapy after radical prostatectomy: clinical considerations.

V. Khoo, A. Mitra, 2009, Surgical oncology.

Painful testicular metastasis from prostate adenocarcinoma

V. Khoo, E. Mayer, Karla A. Lee, 2017, BMJ Case Reports.

Initial UK Experience of Stereotactic Body Radiotherapy for Extracranial Oligometastases: Can We Change the Therapeutic Paradigm?

V. Khoo, D. Tait, H. Mandeville, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial.

V. Khoo, Z. Filipovic, N. Vogelzang, 2022, JAMA oncology.

Comparison of MRI with CT for the radiotherapy planning of prostate cancer: a feasibility study.

D P Dearnaley, V S Khoo, A R Padhani, 1999, The British journal of radiology.

122: CORE: A randomised trial of COnventional care versus Radioablation (stereotactic body radiotherapy) for Extracranial oligometastases

V. Khoo, N. V. As, K. Franks, 2017 .

Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder Cancer

R. Huddart, V. Khoo, J. Staffurth, 2020, International journal of radiation oncology, biology, physics.

Clinical implementation of adaptive hypofractionated bladder radiotherapy for improvement in normal tissue irradiation.

D. Dearnaley, A. Horwich, R. Huddart, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

The use of PET in assessing tumor response after neoadjuvant chemoradiation for rectal cancer.

V. Khoo, D. L. Joon, M. L. Joon, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Evaluating inter-fractional changes in volume and position during bladder radiotherapy and the effect of volume limitation as a method of reducing the internal margin of the planning target volume.

A. Horwich, R. Huddart, V. Khoo, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI.

D P Dearnaley, V S Khoo, A R Padhani, 1999, International journal of radiation oncology, biology, physics.

The dosimetric consequences of anatomic changes in head and neck radiotherapy patients

V. Khoo, D. L. Joon, J. Cox, 2010, Journal of medical imaging and radiation oncology.

A comparative evaluation of the impact of nurse specialists on clinical outcomes in patients with prostate cancer

V. Khoo, A. Richardson, E. Ream, 2008 .

Clinical management and research priorities for high-risk prostate cancer in the UK: Meeting report of a multidisciplinary panel in conjunction with the NCRI Prostate Cancer Clinical Studies Localised Subgroup

V. Khoo, K. Muir, P. Sooriakumaran, 2016 .

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

Katherine M. Tucker, L. Kiemeney, H. Grönberg, 2011, BJU international.

Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)

D. Dearnaley, V. Khoo, C. Parker, 2021, European urology oncology.

A feasibility study of using gold seeds as fiducial markers for bladder localization during radical radiotherapy.

A. Horwich, R. Huddart, V. Khoo, 2007, The British journal of radiology.

Prostate cancer segregation analyses using 4390 families from UK and Australian population‐based studies

D. English, R. Eeles, G. Giles, 2009, Genetic epidemiology.

Improving the diagnosis and treatment of high‐risk localised or locally advanced prostate cancer

V. Khoo, C. Moore, N. Clarke, 2015 .

Prostate‐specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time

Alan Horwich, Robert Huddart, Vincent Khoo, 2009, BJU international.

66 Supra-additive apoptotic response in predominantly quiescent prostate tumors when treated with androgen ablation and radiotherapy

V. Khoo, M. Hasegawa, A. Pollack, 1996 .

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)

D. Dearnaley, V. Khoo, J. Staffurth, 2019, International journal of radiation oncology, biology, physics.

Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma.

V. Khoo, C. West, R. Swindell, 2003, International journal of radiation oncology, biology, physics.

Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancer.

D. Dearnaley, A. Horwich, R. Huddart, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiotherapy of prostate cancer.

V. Khoo, V Khoo, 2011, European journal of cancer.

Localised prostate cancer – new surgical and radiation techniques: Radical radiotherapy – Techniques, results and side effects (evolving tools in definitive radiotherapy, intensity modulated radiotherapy, image guided radiotherapy and their role in dose escalation)

V. Khoo, 2007 .

Whole‐body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer

R. Eeles, A. Horwich, V. Khoo, 2009, Journal of medical imaging and radiation oncology.

Prostate stereotactic body radiotherapy—first UK experience.

V. Khoo, P. Hoskin, N. Van As, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

X-ray volume imaging in bladder radiotherapy verification.

James Wylie, Julia Stratford, Ali Amer, 2006, International journal of radiation oncology, biology, physics.

Towards individualised radiotherapy for Stage I seminoma.

V. Khoo, D. L. Joon, Jarad Martin, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?

V. Khoo, A. Sohaib, N. Van As, 2013, Radiation Oncology.

Comparison of setup accuracy and intrafraction motion using stereotactic frame versus 3-point thermoplastic mask-based immobilization for fractionated cranial image guided radiation therapy.

Kevin Burke, Michelle Long, Ulrike Schick, 2013, Practical radiation oncology.

The effect of an intensive nutritional program on daily set‐up variations and radiotherapy planning margins of head and neck cancer patients

V. Khoo, D. L. Joon, M. Wada, 2009, Journal of medical imaging and radiation oncology.

Intraprostatic fiducials for image guidance: Workflow implications in a single linac department

Andrew See, A. Rolfo, Vincent Khoo, 2008 .

A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy.

P. Evans, D. Dearnaley, V. Khoo, 2008, International journal of radiation oncology, biology, physics.

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer

D. Dearnaley, V. Khoo, C. Parker, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Exploratory models comparing ethiodized oil-glue and gold fiducials for bladder radiotherapy image-guidance

V. Khoo, N. Lawrentschuk, Rachel O’Meara, 2021, Physics and imaging in radiation oncology.

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity

D. Dearnaley, V. Khoo, S. Hassan, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

Comparison of 2D and 3D algorithms for adding a margin to the gross tumor volume in the conformal radiotherapy planning of prostate cancer.

D P Dearnaley, V S Khoo, J L Bedford, 1998, International journal of radiation oncology, biology, physics.

Intensity Modulated Radiotherapy (IMRT) Can Safely Deliver 60 Gy to the Pelvic Lymph Node Regions in Patients with Prostate Cancer: Report of a Phase I Dose Escalation Study

D. Dearnaley, A. Horwich, R. Huddart, 2009 .

The Current Status of PSMA PET-CT for Evaluating Biochemical PSA Relapse in Prostate Cancer

V. Khoo, K. Chan, 2016, Current Radiology Reports.

Treatment of early prostate cancer: radiotherapy, including brachytherapy

V. Khoo, A. Tree, 2009 .

Utilisation of portal imaging in positional control

V. Khoo, 2004 .

Adaptive-predictive organ localization using cone-beam computed tomography for improved accuracy in external beam radiotherapy for bladder cancer.

Alan Horwich, Susan Lalondrelle, Robert Huddart, 2011, International journal of radiation oncology, biology, physics.

Interobserver variation in clinical target volume (CTV) delineation for stereotactic radiotherapy to non-spinal bone metastases in prostate cancer: CT, MRI and PET/CT fusion.

V. Khoo, N. Van As, Daniel Levine, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Improving the surgical treatment of high‐risk localised or locally advanced prostate cancer

V. Khoo, C. Moore, N. Clarke, 2015 .

Degarelix as neoadjuvant hormone therapy in patients with prostate cancer: Results from a phase IIIb randomized, comparative trial versus goserelin plus bicalutamide.

V. Khoo, T. Wiegel, S. Guérif, 2012 .

Simultaneous optimization of beam orientations and beam weights in conformal radiotherapy.

C G Rowbottom, V S Khoo, S Webb, 2001, Medical physics.

Beyond the Knife in Renal Cell Carcinoma: A Systematic Review—To Ablate or Not to Ablate?

V. Khoo, A. Taylor, Harshani Green, 2023, Cancers.

Prostate cancer: current status, new developments and applications in radiotherapy.

V. Khoo, D. Loblaw, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: an assessment of procedure related morbidity, patient acceptability and accuracy.

V. Khoo, J. Logue, A. Henry, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer

V. Khoo, T. Wiegel, V. Fonteyne, 2023, Clinical and translational radiation oncology.

A clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy

V. Khoo, N. Lawrentschuk, F. Foroudi, 2023, Frontiers in Oncology.

A phantom study to contrast and compare polymer and gold fiducial markers in radiotherapy simulation imaging

V. Khoo, F. Foroudi, M. Tacey, 2021, Scientific Reports.

A comparison of multileaf collimator with conformal blocks for the boost phase of dose-escalated conformal prostate radiotherapy.

V. Khoo, J. Bedford, A. Warrington, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer.

D. Dearnaley, V. Khoo, C. Clark, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

Ultrasound imaging to assess inter- and intra-fraction motion during bladder radiotherapy and its potential as a verification tool.

P Price, V. Khoo, B. Taylor, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

Improved Normal Tissue Sparing in Head and Neck Radiotherapy Using Biological Cost Function Based-IMRT

V. Khoo, D. L. Joon, C. Lawford, 2011, Technology in cancer research & treatment.

Combined Low Dose Rate Brachytherapy and External Beam Radiation Therapy for Intermediate-Risk Prostate Cancer.

V. Khoo, D. Bolton, D. L. Joon, 2019, Journal of medical imaging and radiation sciences.

8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group

D. Dearnaley, V. Khoo, J. Logue, 2015 .

Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.

J. Ajani, V. Khoo, R. Pazdur, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Does magnetic resonance imaging of the spine have a role in the staging of prostate cancer?

R. Eeles, D. Dearnaley, A. Horwich, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

A planning-based feasibility study of MR-Linac treatment for anal cancer radiation therapy.

V. Khoo, F. Foroudi, D. Lim Joon, 2023, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

Nuno A. Fonseca, Benjamin J. Raphael, Allison P. Heath, 2020, Nature Communications.

Improving the diagnosis and treatment of high‐risk localised or locally advanced prostate cancer

V. Khoo, C. Moore, N. Clarke, 2015 .

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

V. Khoo, N. Lawrentschuk, N. Hardcastle, 2018, BMC Cancer.

Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial

V. Khoo, A. Gentry-Maharaj, C. Patrono, 2023, British Journal of Cancer.

Prostate‐specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time

D. Dearnaley, A. Horwich, R. Huddart, 2009, BJU international.

The PACE trial: International randomised study of laparoscopic prostatectomy vs. stereotactic body radiotherapy (SBRT) and standard radiotherapy vs. SBRT for early stage organ-confined prostate cancer.

V. Khoo, A. Tree, K. Morrison, 2018 .

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

D. Dearnaley, V. Khoo, C. Parker, 2016, The Lancet. Oncology.

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

L. Kiemeney, L. Andrews, R. Eeles, 2018, British Journal of Cancer.

A case study comparing the relative benefit of optimizing beam weights, wedge angles, beam orientations and tomotherapy in stereotactic radiotherapy of the brain.

C G Rowbottom, V S Khoo, M Oldham, 1998, Physics in medicine and biology.

Title : A randomised assessment of image guided radiotherapy within a phase 3 trial of Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer ( CHHiP )

Parker, D. Dearnaley, V. Khoo, 2018 .